FDC LtdPharmaceuticalsINE258B01022Consolidated₹362.40+9.90 (+2.81%)Jun-26
Valuation
Market Cap₹5.90K Cr
TTM PE20.16x
Forward PE16.75x
PEG5.05
Book Value₹152.64
P/B2.37x
TTM EPS₹17.98
Fwd EPS₹21.64
TTM Revenue₹2.19K Cr
TTM PAT₹292.56 Cr
TTM EBITDA₹335.45 Cr
TTM EBIT₹275.99 Cr
Last Qtr PAT₹132.49 Cr
Last Qtr EBITDA₹143.00 Cr
Last Qtr EBIT₹127.87 Cr
Profitability
ROE11.77%
ROCE15.73%
TTM NPM13.36%
TTM EBITDA %15.32%
Curr OPM18.52%
Last OPM16.29%
Curr NPM
Last NPM
Curr EPS₹8.14
Last EPS₹6.35
Balance sheet
Equity₹16.28 Cr
Reserve₹2.47K Cr
Total Debt₹20.12 Cr
D/E0.01x
Interest %0.63%
Curr Interest₹0.83 Cr
Price / range
Close₹362.40
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+2.81%
1W+6.14%
1M+3.96%
3M-6.92%
6M+8.85%
1Y-25.47%
2Y-35.77%
3Y-1.92%
5Y+2.87%
Diwali-13.71%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1868.90₹4.48L Cr37.0814.50%
DIVISLAB9410.50₹2.50L Cr85.3917.45%
TORNTPHARM4970.00₹1.89L Cr79.3925.70%
ZYDUSLIFE1161.00₹1.16L Cr25.8716.94%
CIPLA1386.10₹1.12L Cr33.219.75%
LAURUSLABS2017.50₹1.09L Cr99.5820.58%
MANKIND2437.80₹1.01L Cr49.2612.68%
DRREDDY1198.30₹1.00L Cr30.978.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue655.10+2.0%564.36457.94461.74642.282,126.33
Other Income47.3447.1622.0720.9135.59111
Total Income702.44+3.6%611.53480.01482.65677.872,237.33
Interest0.821.501.121.151.164.92
Expenditure-528.17-2.2%-468.56-424.20-443.16-516.98-1,838.18
PBDT000000
EBITDA142.84+1.1%111.6149.6134.90141.33352.17
Depreciation-15.09-14.31-14.75-15.17-14.87-59.10
EBIT127.75+1.0%97.3034.8619.73126.46293.07
PBT174.27+8.3%142.9635.0239.49160.88378.36
Tax-42.25-35.89-7.84-10.02-38.69-92.44
Equity16.2816.2816.28016.2816.28
OPM24.8123.387.308.5523.7316.91
Net Profit132.02+8.0%107.0727.1929.48122.19285.92
NPM18.7917.515.666.3818.0312.78
EPS8.11+8.0%6.581.671.817.5117.56

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,126.33+2.7%2,070.11+8.0%1,916.19+7.8%1,777.03+17.0%1,518.97+14.6%1,325.45
Other Income111105.52103.2253.9178.7397.15
Total Income2,237.33+2.8%2,175.63+7.7%2,019.40+10.3%1,830.94+14.6%1,597.70+12.3%1,422.60
Expenditure-1,838.18-1.7%-1,807.96-11.5%-1,621.46-3.6%-1,565.25-19.3%-1,312.25-25.9%-1,042.15
Interest-4.92-4.49-4-4.04-3.05-3.40
PBDT000000
EBITDA352.17+10.0%320.25-5.4%338.46+32.9%254.58+3.1%246.85-23.9%324.32
Depreciation-59.10-53.61-39.73-38.76-37.08-37.62
EBIT293.07+9.9%266.64-10.7%298.73+38.4%215.82+2.9%209.77-26.8%286.70
PBT378.36+2.9%367.67-7.6%397.95+49.8%265.69-6.9%285.45-25.0%380.45
Tax-92.44-94.05-90.78-64.73-65.82-85.96
Equity16.2816.280000
OPM (%)16.9116.9020.0015.0018.0027.00
Net Profit285.92+4.5%273.63-10.9%307.16+52.8%200.97-8.5%219.64-25.4%294.49
NPM (%)12.7812.5815.0011.0014.0021.00
EPS (Rs)17.56+4.5%16.81-10.1%18.70+54.7%12.09-7.1%13.01-24.9%17.32
CEPS17.5616.8118.7012.0913.0117.32

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue667.69+3.0%584.79464.71473.03648.412,170.93
Other Income47.6649.8920.8020.6235.50113.52
Total Income715.35+4.6%634.68485.51493.66683.912,284.45
Interest0.831.551.121.151.174.99
Expenditure-540.65-3.2%-494.33-428.33-455.57-524.13-1,889.06
PBDT000000
EBITDA143+1.9%106.3652.2833.81140.36346.10
Depreciation-15.13-14.35-14.78-15.20-14.91-59.24
EBIT127.87+1.9%92.0137.5018.61125.45286.86
PBT174.70+9.3%140.3536.3838.09159.78374.60
Tax-42.21-36.95-8.08-9.72-38.42-93.18
Equity16.2816.280016.2816.28
OPM24.4222.117.497.7223.3616.40
Net Profit132.49+9.2%103.4028.3028.37121.35281.42
NPM18.5216.295.835.7517.7412.32
EPS8.14+9.3%6.351.741.757.4517.29

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,170.93+3.0%2,108.12+8.5%1,942.94+8.9%1,783.75+16.7%1,527.92+14.6%1,333.20
Other Income113.5290.66101.6349.8676.1097.03
Total Income2,284.45+3.9%2,198.78+7.5%2,044.58+11.5%1,833.61+14.3%1,604.01+12.2%1,430.23
Expenditure-1,889.06-2.6%-1,841.56-11.7%-1,648.36-4.6%-1,575.80-19.9%-1,314.62-26.4%-1,040.39
Interest-4.99-4.51-4.03-4.09-3.09-3.43
PBDT000000
EBITDA346.10+6.6%324.80-4.1%338.53+34.9%250.98-1.1%253.69-24.1%334.05
Depreciation-59.24-53.73-39.92-38.94-37.30-37.81
EBIT286.86+5.8%271.07-9.2%298.61+40.8%212.04-2.0%216.39-27.0%296.24
PBT374.60+4.9%357.22-9.8%396.22+53.7%257.80-10.9%289.39-25.4%387.71
Tax-93.18-90.43-91.16-63.98-73.23-86.53
Equity16.2816.280000
OPM (%)16.4016.2519.3814.0618.0427.11
Net Profit281.42+5.5%266.79-12.5%305.06+57.4%193.83-10.3%216.17-28.2%301.20
NPM (%)12.3212.1314.9210.5713.4821.06
EPS (Rs)17.29+5.5%16.39-11.8%18.58+59.3%11.66-9.0%12.81-27.7%17.72
CEPS17.2916.3918.5811.6612.8117.72

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

13
YearTypeAmountEx-Date
2026Interim Dividend511 Feb 2026
2025Interim Dividend522 Nov 2024
2020Interim Dividend0.819 Mar 2020
2017Final Dividend2.2508 Aug 2017
2016Interim Dividend2.2517 Mar 2016
2015Final Dividend2.2523 Sep 2015
2014Final Dividend2.2528 Jul 2014
2013Final Dividend2.2520 Aug 2013
2012Final Dividend206 Aug 2012
2011Final Dividend213 Sep 2011
2010Final Dividend1.7510 Aug 2010
2009Final Dividend1.2517 Aug 2009
2008Final Dividend118 Aug 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers